Shafiullah Shaik, Dhaneshwar Suneela
Amity Institute of Pharmacy, Lucknow, Amity University Uttar Pradesh, Sector 125, Noida, U.P., India.
Department of Pharmaceutical Chemistry, Amity Institute of Pharmacy, Amity University Maharashtra, Mumbai, Maharashtra, India.
Curr Mol Med. 2025;25(3):289-304. doi: 10.2174/1566524023666230522145950.
Attention-deficit hyperactivity disorder (ADHD) is a neurobiological and neurodevelopmental disorder with an idiosyncratic genetic base. ADHD presents various characteristics, such as inattention, hyperactivity, and impulsivity. Over the period, ADHD leads to noticeable functional disability. A five- to ten-fold progressed risk of disorder development is observed in the populations with familial history of ADHD. The abnormal structure of the brain in ADHD results in altered neural mechanisms, such as cognition, attention, and memorial function. The mesolimbic, nigrostriatal, and mesocortical pathways in the brain get affected by the deterioration of the levels of dopamine. The hypothesis of dopamine in ADHD and its etiopathology suggests that detained attention and impaired arousal functions are due to reduced levels of dopamine. The quickest way to improve strategical treatment is by clarifying the etiological aspects of ADHD and identifying the underlying mechanisms of pathophysiology, which will assist in exploring the biomarkers for better diagnosis. The implementation of life course theory is a very important research principle announced by Grand Challenges in Global Health Initiative (GCMHI). Long-term research is needed to define the progression of ADHD. Interdisciplinary collaborations promise a great future for research innovations in ADHD.
注意力缺陷多动障碍(ADHD)是一种具有独特遗传基础的神经生物学和神经发育障碍。ADHD具有多种特征,如注意力不集中、多动和冲动。随着时间的推移,ADHD会导致明显的功能障碍。在有ADHD家族史的人群中,观察到疾病发展风险提高了五到十倍。ADHD患者大脑结构异常会导致神经机制改变,如认知、注意力和记忆功能。大脑中的中脑边缘、黑质纹状体和中脑皮质通路会因多巴胺水平下降而受到影响。ADHD中多巴胺及其病因学假说表明,注意力不集中和唤醒功能受损是由于多巴胺水平降低所致。改善策略性治疗的最快方法是阐明ADHD的病因学方面,并确定病理生理学的潜在机制,这将有助于探索更好诊断的生物标志物。生命历程理论的实施是全球卫生倡议重大挑战(GCMHI)宣布的一项非常重要的研究原则。需要进行长期研究来确定ADHD的发展过程。跨学科合作有望为ADHD的研究创新带来广阔前景。
Curr Mol Med. 2025
Expert Rev Neurother. 2010-4
Med Sci (Paris). 2010-5
Neurosci Biobehav Rev. 2007
Nervenarzt. 2008-7
Trends Neurosci. 2009-1
Neurosci Biobehav Rev. 2000-1
Neural Regen Res. 2025-9-1
Antioxidants (Basel). 2020-10-23
Atten Defic Hyperact Disord. 2015-12